Insider Transactions in Q2 2025 at Agios Pharmaceuticals, Inc. (AGIO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2025
|
Sarah Gheuens Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,909
-4.86%
|
$95,997
$33.54 P/Share
|
|
Jun 24
2025
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+9.11%
|
-
|
|
Jun 24
2025
|
James William Burns Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,799
-8.9%
|
$92,367
$33.54 P/Share
|
|
Jun 24
2025
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+16.02%
|
-
|
|
Jun 24
2025
|
Brian Goff Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,700
-7.93%
|
$617,100
$33.54 P/Share
|
|
Jun 24
2025
|
Brian Goff Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,277
+13.77%
|
-
|
|
Jun 24
2025
|
Tsveta Milanova Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,770
-9.59%
|
$91,410
$33.54 P/Share
|
|
Jun 24
2025
|
Tsveta Milanova Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+17.2%
|
-
|
|
Jun 24
2025
|
Cecilia Jones Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,780
-5.59%
|
$58,740
$33.54 P/Share
|
|
Jun 24
2025
|
Cecilia Jones Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+15.86%
|
-
|
|
Jun 20
2025
|
Jeffrey D Capello Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,120
+25.88%
|
-
|
|
Jun 20
2025
|
Rahul D. Ballal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,120
+17.33%
|
-
|
|
Jun 20
2025
|
Catherine E. Owen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,120
+25.88%
|
-
|
|
Jun 20
2025
|
Maykin Ho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,120
+11.07%
|
-
|
|
Jun 20
2025
|
Jacqualyn A Fouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,120
+1.38%
|
-
|
|
Jun 20
2025
|
Kaye I Foster Cheek Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,120
+22.11%
|
-
|
|
Jun 20
2025
|
Cynthia Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,120
+17.33%
|
-
|
|
Jun 20
2025
|
David Scadden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,120
+10.75%
|
-
|
|
Jun 13
2025
|
Catherine E. Owen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,977
+33.34%
|
-
|
|
Jun 13
2025
|
Jeffrey D Capello Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,977
+33.34%
|
-
|
|
Apr 10
2025
|
Jacqualyn A Fouse Director |
SELL
Open market or private sale
|
Direct |
7,497
-4.78%
|
$187,425
$25.9 P/Share
|
|
Apr 08
2025
|
Jacqualyn A Fouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,933
+9.23%
|
-
|